CIK 2038158
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 82.12% | 21 |
| Unclassified | 17.88% | 3 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | TERNS PHARMACEUTICALS INC | Unclassified | 14.80% | |
| 2 | PTGX | Protagonist Therapeutics, Inc | Health Care | 11.24% |
| 3 | STTK | Shattuck Labs, Inc. | Health Care | 9.40% |
| 4 | VOR | Vor Biopharma Inc. | Health Care | 8.28% |
| 5 | CMPS | COMPASS Pathways plc | Health Care | 5.19% |
| 6 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Health Care | 5.09% |
| 7 | XENE | Xenon Pharmaceuticals Inc. | Health Care | 4.95% |
| 8 | PVLA | PALVELLA THERAPEUTICS, INC. | Health Care | 4.79% |
| 9 | ZBIO | Zenas BioPharma, Inc. | Health Care | 3.87% |
| 10 | IVA | Inventiva S.A. | Health Care | 3.44% |
21/24 names classified · sector 82.1% of weight · industry 82.1% · mkt cap 78.7%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 82.1% of the book is sector-classified (unclassified names shown, never dropped).
Only 0% of book weight classified — the grid is NOT representative of the whole book.
Classified: 0.0% of book weight (0/23 names) · unclassified 100.0%: , PTGX, STTK, VOR, CMPS, RYTM, XENE, PVLA, ZBIO, IVA +13 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | TERNS PHARMACEUTICALS INC | 604,534 | $32M | 14.8% | ADD 10% |
| 2 | PTGXPROTAGONIST THERAPEUTICS INC | 229,619 | $24M | 11.2% | HOLD |
| 3 | STTKSHATTUCK LABS INC | 3,149,907 | $20M | 9.4% | HOLD |
| 4 | VORVOR BIOPHARMA INC | 999,967 | $18M | 8.3% | HOLD |
| 5 | CMPSCOMPASS PATHWAYS PLC | 2,021,407 | $11M | 5.2% | ADD 169% |
| 6 | RYTMRHYTHM PHARMACEUTICALS INC | 126,078 | $11M | 5.1% | ADD 87% |
| 7 | XENEXENON PHARMACEUTICALS INC | 183,225 | $11M | 4.9% | HOLD |
| 8 | PVLAPALVELLA THERAPEUTICS INC | 82,686 | $10M | 4.8% | HOLD |
| 9 | ZBIOZENAS BIOPHARMA INC | 426,736 | $8M | 3.9% | ADD 33% |
| 10 | IVAINVENTIVA SA | 1,333,484 | $7M | 3.4% | ADD 3% |
| 11 | VSTMVERASTEM INC | 1,306,800 | $7M | 3.2% | HOLD |
| 12 | CBIOCRESCENT BIOPHARMA INC. | 372,856 | $7M | 3.2% | HOLD |
| 13 | ORICORIC PHARMACEUTICALS INC | 523,619 | $7M | 3.1% | TRIM −15% |
| 14 | GPCRSTRUCTURE THERAPEUTICS INC | 133,239 | $6M | 3.0% | ADD 41% |
| 15 | PCVXVAXCYTE INC | 95,223 | $6M | 2.6% | HOLD |
| 16 | COGTCOGENT BIOSCIENCES INC | 131,188 | $5M | 2.3% | ADD 37% |
| 17 | CMPXCOMPASS THERAPEUTICS INC | 848,204 | $4M | 2.1% | TRIM −24% |
| 18 | EVMNEVOMMUNE INC | 184,063 | $4M | 2.0% | TRIM −19% |
| 19 | OCSOCULIS HOLDING AG | 149,592 | $4M | 1.8% | HOLD |
| 20 | ZLABZAI LAB LTD | 183,362 | $3M | 1.6% | ADD 12% |
| 21 | IRONDISC MEDICINE INC | 52,655 | $3M | 1.6% | ADD 23% |
| 22 | KALVISTA PHARMACEUTICALS INC | 131,796 | $3M | 1.2% | HOLD |
| 23 | SMMTSUMMIT THERAPEUTICS INC | 89,717 | $2M | 0.8% | NEW |
| 24 | ACETADICET BIO INC | 157,827 | $1M | 0.5% | HOLD |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| TERNS PHARMACEUTICALS INC | — | — | — | — | 551K | 605K | $32M |
| PTGXPROTAGONIST THERAPEUTICS INC | — | — | — | — | 230K | 230K | $24M |
| STTKSHATTUCK LABS INC | — | — | — | — | 3.1M | 3.1M | $20M |
| VORVOR BIOPHARMA INC | — | — | — | — | 1000K | 1000K | $18M |
| CMPSCOMPASS PATHWAYS PLC | — | — | — | — | 753K | 2.0M | $11M |
| RYTMRHYTHM PHARMACEUTICALS INC | — | — | — | — | 68K | 126K | $11M |
| XENEXENON PHARMACEUTICALS INC | — | — | — | — | 184K | 183K | $11M |
| PVLAPALVELLA THERAPEUTICS INC | — | — | — | — | 83K | 83K | $10M |
| ZBIOZENAS BIOPHARMA INC | — | — | — | — | 322K | 427K | $8M |
| IVAINVENTIVA SA | — | — | — | — | 1.3M | 1.3M | $7M |
| VSTMVERASTEM INC | — | — | — | — | 1.3M | 1.3M | $7M |
| CBIOCRESCENT BIOPHARMA INC. | — | — | — | — | 373K | 373K | $7M |
| ORICORIC PHARMACEUTICALS INC | — | — | — | — | 616K | 524K | $7M |
| GPCRSTRUCTURE THERAPEUTICS INC | — | — | — | — | 94K | 133K | $6M |
| PCVXVAXCYTE INC | — | — | — | — | 95K | 95K | $6M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
